Insider trades

Simon Read, Director of Dianthus Therapeutics DNTH, has filed 2 transactions, none an open-market purchase or sale. The latest trade was on 05/21.

Simon Read

Director
First filing
25/05/22
Trades
2 trades
Buys / sales
0 / 0
12-month net buying
No record
Last trade
05/21

Trading activity

Transactions

No filed transactions.